New vaccine aims to shield infants from deadly meningitis
NCT ID NCT07505810
First seen Apr 05, 2026 · Last updated Jun 05, 2026 · Updated 10 times
Summary
This study tests a new vaccine to protect babies aged 3 to 5 months against meningitis caused by four types of bacteria (A, C, Y, W135). About 880 infants will receive either the new vaccine or an existing one to compare safety and immune response. The goal is to see if the new vaccine works as well or better at preventing this serious infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDEMIC MENINGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.